These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1080062)
1. Studies of the human factor VIII/von Willebrand's factor protein. II. Identification and characterization of the von Willebrand protein. Gralnick HR; Coller BS Blood; 1975 Sep; 46(3):417-30. PubMed ID: 1080062 [TBL] [Abstract][Full Text] [Related]
2. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944 [TBL] [Abstract][Full Text] [Related]
3. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease. Gralnick HR; Coller BS; Sultan Y J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the defect of the factor VIII/von Willebrand factor protein in von Willebrand's disease. Gralnick HR; Cregger MC; Williams SB Blood; 1982 Mar; 59(3):542-8. PubMed ID: 6800417 [TBL] [Abstract][Full Text] [Related]
5. Inherited variants of factor-VIII-related protein in von Willebrand's disease. Peake IR; Bloom AL; Giddings JC N Engl J Med; 1974 Jul; 291(3):113-7. PubMed ID: 4546110 [No Abstract] [Full Text] [Related]
6. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy. Lian EC; Deykin D Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143 [TBL] [Abstract][Full Text] [Related]
7. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. Weiss HJ; Sussman II; Hoyer LW J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621 [TBL] [Abstract][Full Text] [Related]
8. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. Weiss HJ; Rogers J; Brand H J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262 [TBL] [Abstract][Full Text] [Related]
9. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas. Bennett B; Forman WB; Ratnoff OD J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413 [TBL] [Abstract][Full Text] [Related]
10. Family studies of patients with reduced ristocetin aggregation and abnormalities of factor VIII and/or platelet function. Ekert H; Ananthakrishnan R; Muntz RH; Dowling S; D'Souza S Thromb Haemost; 1976 Aug; 36(1):78-85. PubMed ID: 1087478 [TBL] [Abstract][Full Text] [Related]
11. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease. Sultan Y; Simeon J; Caen JP J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003 [TBL] [Abstract][Full Text] [Related]
12. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease. Zimmerman TS; Voss R; Edgington TS J Clin Invest; 1979 Nov; 64(5):1298-302. PubMed ID: 315413 [TBL] [Abstract][Full Text] [Related]
13. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation. Kinoshita S; Yoshioka K; Kasahara M; Takamiya O Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773 [TBL] [Abstract][Full Text] [Related]
14. Abnormalities of factor VIII and platelet aggregation--use of ristocetin in diagnosing the von Willebrand syndrome. Weiss HJ Blood; 1975 Mar; 45(3):403-12. PubMed ID: 1078779 [TBL] [Abstract][Full Text] [Related]
15. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor. Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626 [TBL] [Abstract][Full Text] [Related]
16. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease. Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054 [TBL] [Abstract][Full Text] [Related]
17. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976 [TBL] [Abstract][Full Text] [Related]
18. Heat-treated factor VIII/von Willebrand factor concentrate in platelet-type von Willebrand's disease. Takahashi H; Tatewaki W; Nagayama R; Hanano M; Tamura M; Yamaguchi T; Takizawa S; Wada K; Shibata A Haemostasis; 1987; 17(6):353-60. PubMed ID: 3123334 [TBL] [Abstract][Full Text] [Related]
19. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers. Weiss HJ; Sussman II Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353 [TBL] [Abstract][Full Text] [Related]
20. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor. Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]